von Redaktion LCGC | Apr. 15, 2010
Synthesis and biological evaluation of 4-anilinoquinolines as potent inhibitors of epidermal growth factor receptor Pawar VG, Sos ML, Rode HB, Rabiller M, Heynck S, van Otterlo WA, Thomas RK, Rauh D Journal: Journal of Medicinal Chemistry, Vol 53, No 7, April 2010,...
von Redaktion LCGC | März 15, 2010
Osteoblastic response in patients with non-small cell lung cancer with activating EGFR Mutations and bone metastases during treatment with EGFR kinase inhibitors Ansén S, Bangard C, Querings S, Gabler F, Scheffler M, Seidel D, Saal B, Zander T, Nogová L, Töpelt K,...
von Redaktion LCGC | Feb. 15, 2010
Identification of lung cancer with high sensitivity and specificity by blood testing Leidinger P, Keller A, Heisel S, Ludwig N, Rheinheimer S, Klein V, Andres C, Staratschek-Jox A, Wolf J, Stoelben E, Stephan B, Stehle I, Hamacher J, Huwer H, Lenhof H P and Meese E...
von Redaktion LCGC | Feb. 15, 2010
Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation Sos ML, Rode HB, Heynck S, Peifer M, Fischer F, Klüter S, Pawar VG, Reuter C, Heuckmann JM, Weiss J,...
von Redaktion LCGC | Jan. 15, 2010
Analysis of compound synergy in high-throughput cellular screens by population-based lifetime modeling Peifer M, Weiss J, Sos ML, Koker M, Heynck S, Netzer C, Fischer S, Rode H, Rauh D, Rahnenführer J, Thomas RK Journal: PLoS One, Vol 5, No 1, January 2010, doi:...
